Skip to content

The blood protective effect of acute isovolumetric hemodilution combined with intraoperative blood recovery in revision total hip arthroplasty

The blood protective effect of acute isovolumetric hemodilution combined with intraoperative blood recovery in revision total hip arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098940
Enrollment
Unknown
Registered
2025-03-17
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periprosthetic fracture after hip replacement surgery

Interventions

Acute isovolumetric blood dilution group:After stable anesthesia induction, blood was drawn from the internal jugular vein (at a rate of 20ml/min) and stored in a blood collection bag containing sodiu
Intraoperative blood recovery group:This study used a Jingjing 3000P blood recovery machine to recover surgical bleeding. Anticoagulants were added to 500ml of compound sodium chloride solution with 2
Acute isovolumetric blood dilution combined with intraoperative blood recovery group:After stable anesthesia induction, blood wa

Sponsors

Xi'an Honghui Hospital Affiliated to Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) score I-II; 2. Preoperative hemoglobin >= 110g/L, hematocrit >= 35%, platelet count >= 100 × 10^9/L; 3. Expected intraoperative bleeding>500ml; 4. Normal coagulation function, normal heart, lung, liver, and kidney function, and no history of taking anticoagulant drugs; 5. The patient signs an informed consent form for anesthesia.

Exclusion criteria

Exclusion criteria: 1. Individuals with contraindications to general anesthesia or a history of anesthesia accidents; 2. Hemoglobin<100g/L, hypoalbuminemia, platelet and coagulation dysfunction; 3. Patients with combined traumatic brain injury, intracranial hypertension, stroke, unstable angina, and myocardial infarction; 4. Respiratory dysfunction, obstructive pulmonary disease, presence of difficult airways, or difficulty in endotracheal intubation (modified Mahalanobis score III or IV); 5. Uncontrolled diabetes or hypertension; 6. Severe liver dysfunction or severe renal insufficiency; 7. History of alcoholism or drug dependence; 8. Abuse or long-term use of anesthetics, sedatives, and analgesics; 9. Individuals with a history of mental illness; 10. Pregnant and lactating women; Women or men with fertility are unwilling to use contraception throughout the entire trial period; Subjects with pregnancy plans within one month after the trial (including male subjects); 11. The researchers believe that there are any other factors that are not suitable for participants in this experiment.

Design outcomes

Primary

MeasureTime frame
heart rate;mean arterial pressure;central venous pressure;Hemoglobin concentration;prothrombin time;activated partial thromboplastin time;

Secondary

MeasureTime frame
hematocrit;Intraoperative blood loss;Postoperative infection;Postoperative hospitalization time;

Countries

China

Contacts

Public ContactGuang Yang

Anesthesia Department of Xi'an Red Cross Hospital Affiliated to Xi'an Jiaotong University

850303584@qq.com+86 183 3472 0591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026